Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.

Bado I, Nikolos F, Rajapaksa G, Wu W, Castaneda J, Krishnamurthy S, Webb P, Gustafsson JÅ, Thomas C.

Breast Cancer Res. 2017 Jul 3;19(1):79. doi: 10.1186/s13058-017-0872-z.

2.

Estrogen signaling and unfolded protein response in breast cancer.

Rajapaksa G, Thomas C, Gustafsson JÅ.

J Steroid Biochem Mol Biol. 2016 Oct;163:45-50. doi: 10.1016/j.jsbmb.2016.03.036. Epub 2016 Apr 1. Review.

PMID:
27045680
3.

ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.

Bado I, Nikolos F, Rajapaksa G, Gustafsson JÅ, Thomas C.

Oncotarget. 2016 Mar 22;7(12):13599-611. doi: 10.18632/oncotarget.7300.

4.

ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway.

Rajapaksa G, Nikolos F, Bado I, Clarke R, Gustafsson JÅ, Thomas C.

Oncogene. 2015 Jul 30;34(31):4130-41. doi: 10.1038/onc.2014.343. Epub 2014 Oct 27.

PMID:
25347741
5.

ERβ regulates NSCLC phenotypes by controlling oncogenic RAS signaling.

Nikolos F, Thomas C, Rajapaksa G, Bado I, Gustafsson JÅ.

Mol Cancer Res. 2014 Jun;12(6):843-54. doi: 10.1158/1541-7786.MCR-13-0663. Epub 2014 Mar 11.

6.

ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.

Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JÅ.

Breast Cancer Res. 2012 Nov 16;14(6):R148. doi: 10.1186/bcr3358.

Supplemental Content

Loading ...
Support Center